FOXO1 and Insulin resistance: Our previous study showed that piceatannol could inhibit TNF-α-mediated inflammation and insulin resistance in 3T3-L1 adipocytes through Akt-dependent forkhead box O1 (FoxO1) signaling pathway [14].